Addus HomeCare's stock price plummeted 8.81% during intraday trading on Tuesday, following negative analyst actions from Barclays.

The sharp decline came after Barclays maintained its Sell (Underweight) rating on the company and reduced its price target from $117 to $112. Analyst Andrew Mok CFA reaffirmed the negative outlook in reports released just before the market opened, signaling continued bearish sentiment toward the home care services provider.

Such analyst rating downgrades and price target reductions often trigger significant market reactions as they influence investor perceptions and trading decisions, particularly when coming from major financial institutions like Barclays.